Beiträge Aktuelles Di, 10.06.2025 EAST-AFNET 4 Manuscript We are pleased to inform you that the manuscript entitled ‘Impact of diabetes mellitus and obesity on treatment effect of early rhythm control: EAST-AFNET4’ has been accepted for publication in ‘JAMA Cardiology’. Many thanks to all authors and co-authors.
Experts discuss the new S3 guidelines on atrial fibrillation in a webinar.
From May 5–7, 2025, the 10th AFNET EHRA Consensus Conference took place in Gressy, France.
We captured the inspiring atmosphere and some voices of the participants, bringing them together in this aftermovie. A heartfelt thank you to everyone whose ideas and dedication made this event a true success!
Prof Camm was honoured with the AFNET Lecture Award at the AFNET general meeting during the DGK 2025 annual conference in Mannheim. In this document you can see his lecture at the award ceremony.
The MAESTRIA Consortium, which consists of 18 partners from different European countries, met for the 3rd time on 8 and 9 May to discuss the progress of the EU-funded MAESTRIA project.
From May 5 to 7, 2025, the 10th AFNET EHRA Consensus Conference took place in Gressy, France. Below are some impressions of the presentations, breakout sessions and the program around it
Prof. Dr. med. Götz Thomalla (UKE) and Dr. med. Märit Jensen (UKE) have recorded a video on the new EAST-STROKE trial in layman’s terms.
The EAST-STROKE (‘Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE’) trial is led by scientist from the University Medical Centre Hamburg-Eppendorf (UKE) and investigates whether early rhythm-control treatment can effectively and safely prevent strokes. The project is funded by the EU as part of ‘Horizon Europe’. AFNET is partner for dissemination and exploitation.
Patients with an acute stroke and atrial fibrillation have a particularly high risk of a recurrent stroke and other serious cardiovascular events. A Europe-wide clinical trial led by scientists from the University Medical Centre Hamburg-Eppendorf (UKE) is now investigating whether early rhythm-control treatment can effectively and safely prevent strokes.
On behalf of all our members, we would like to congratulate our AFNET founding member Prof Dr Meinertz on his 80th birthday! 🎈
We wish them all the best and good health for the coming years. Thank you very much for your great commitment and tireless dedication to AFNET!
